AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA(ASST DI MANTOVA)

Their core work

ASST di Mantova is a public territorial healthcare authority in Lombardy, Italy, providing hospital and community health services across the Mantova province. In EU research, they contribute clinical expertise and patient populations for multi-centre trials focused on elderly care — particularly stroke prevention, dementia management, and emergency response to infectious disease outbreaks. Their role is that of a frontline clinical partner, bringing real-world hospital data and care protocols to research consortia studying how to improve outcomes for vulnerable patient groups.

What they specialise in

How they've shifted over time

ASST di Mantova began its H2020 involvement in 2015 with a focus on acute stroke care in the elderly (PRECIOUS). From 2018 onward, their attention shifted toward chronic neurological conditions — specifically dementia management and the ethics of restraint and non-drug interventions (RECAGE). The 2020 entry into COVID-19 plasma research (SUPPORT-E) reflects an opportunistic but logical pivot, contributing their blood banking and clinical infrastructure to pandemic response.

Moving from acute care research toward chronic age-related conditions and rapid-response clinical trials, suggesting growing capacity for geriatric and emergency medicine studies.

How they like to work

ASST di Mantova operates exclusively as a consortium participant — they have never coordinated an H2020 project, which is typical for a public hospital contributing clinical sites rather than driving research agendas. With 49 unique partners across 13 countries, they join large multi-centre consortia where their value is providing patient access and clinical implementation. This makes them a reliable, low-friction partner for coordinators who need an Italian hospital site in their trial network.

They have collaborated with 49 distinct partners across 13 countries, indicating broad European reach through large clinical trial consortia. Their network is wide but not deep — spread across many partners rather than concentrated with repeat collaborators.

What sets them apart

As a public territorial health authority (not a university hospital), ASST di Mantova offers access to a community-level patient population in northern Italy — particularly elderly and dementia patients in routine care settings. This is valuable for trials that need real-world clinical environments rather than academic medical centres. Their combination of geriatric medicine, dementia care units, and blood service infrastructure is uncommon in a single regional hospital system.

Highlights from their portfolio

• PRECIOUS
  Largest single EC contribution (EUR 207,490) and a multi-year randomised clinical trial on stroke complications in the elderly — their flagship research involvement.
• RECAGE
  Addresses the ethically complex area of physical restraints and antipsychotic use in dementia care, combining clinical research with health economics and ethics.